Dupilumab in Atopic Dermatitis and What Pharmacists Should Know

It is important for pharmacists to know the latest updates on the right treatment options for atopic dermatitis.

Pharmacy Times spoke with Dr. Peter Lio, assistant professor of dermatology & pediatrics at Northwestern University Feinberg School of Medicine, about dupilumab associated Ocular Surface Disease in patients with atopic dermatitis.

Dr. Lio discussed what drew him and his team into the topic of dupilumab for studies about atopic dermatitis and any significant findings that pharmacists should know when counseling their patients.